-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Integrated Biopharma Inc quarterly Deferred State and Local Income Tax Expense (Benefit) history and growth rate from Q3 2020 to Q1 2024.
- Integrated Biopharma Inc Deferred State and Local Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$14K, a 167% decline year-over-year.
Deferred State and Local Income Tax Expense (Benefit), Quarterly (USD)
Deferred State and Local Income Tax Expense (Benefit), YoY Quarterly Growth (%)